 LAUSANNE, Switzerland, Sept. 02, 2021 GLOBE NEWSWIRE -- AC Immune SA NASDAQ: ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in the following upcoming virtual investor conferences: 